Breaking News Instant updates and real-time market news.

MRTN

Marten Transport

$22.10

(0.00%)

, UAL

United Continental

$72.66

0.38 (0.53%)

19:03
07/17/18
07/17
19:03
07/17/18
19:03

On The Fly: After Hours Movers

UP AFTER EARNINGS: Martin Transport (MRTN) up 6.1%... United Continental (UAL) up 3.6%... CSX (CSX) up 3.3%... Mellanox Technologies (MLNX) up 1.2%... Interactive Brokers (IBKR) up 0.3%. DOWN AFTER EARNINGS: Healthcare Services Group (HCSG) down 5.6%... Texas Instruments (TXN) down 1.6%. ALSO LOWER: Sonic Automotive (SAH) down 11.0% after Q2 guidance miss... Cara Therapeutics (CARA) down 4.7% after equity offering... Casi Pharmaceuticals (CASI) down 3.6% after equity offering... Tillys's (TLYS) down 2.4% after equity offering... Clorox (CLX) down 0.9% after Goldman Sachs downgrade.

MRTN

Marten Transport

$22.10

(0.00%)

UAL

United Continental

$72.66

0.38 (0.53%)

CSX

CSX

$64.42

0.46 (0.72%)

MLNX

Mellanox

$84.85

0.9 (1.07%)

IBKR

Interactive Brokers

$64.65

1.93 (3.08%)

HCSG

Healthcare Services

$42.38

-0.3297 (-0.77%)

TXN

Texas Instruments

$115.80

1.21 (1.06%)

SAH

Sonic Automotive

$20.45

0.3 (1.49%)

CARA

Cara Therapeutics

$21.60

0.435 (2.06%)

CASI

Casi Pharmaceuticals

$7.26

-0.215 (-2.88%)

TLYS

Tilly's

$15.35

0.21 (1.39%)

CLX

Clorox

$135.00

0.71 (0.53%)

  • 17

    Jul

  • 17

    Jul

  • 17

    Jul

  • 18

    Jul

  • 18

    Jul

  • 24

    Jul

  • 02

    Aug

  • 26

    Aug

  • 19

    Jul

MRTN Marten Transport
$22.10

(0.00%)

07/10/18
STFL
07/10/18
DOWNGRADE
STFL
Sell
Marten Transport downgraded to Sell from Hold at Stifel
Stifel analyst David Ross downgraded Marten Transport to Sell from Hold citing valuation and maintained a $200 price target.
01/26/18
01/26/18
UPGRADE

Buy
Marten Transport upgraded to Buy on pricing environment at Seaport Global
As previously reported, Seaport Global upgraded Marten Transport to Buy from Neutral with a $30 price target. Coverage was transitioned to analyst Kevin Sterling who believes we are entering a dynamic pricing environment for refrigerated transportation driven by tightening supply and strong demand. Sterling expects Marten's leverage in the model to begin to show benefits in Q2 2018 as the pricing story plays out.
04/06/18
STFL
04/06/18
INITIATION
Target $20
STFL
Hold
Marten Transport resumed with a Hold at Stifel
Stifel analyst David Ross resumed coverage of Marten Transport with a Hold rating and $20 price target.
04/20/18
SPHN
04/20/18
DOWNGRADE
Target $25
SPHN
Equal Weight
Marten Transport downgraded to Equal Weight from Overweight at Stephens
Stephens analyst Brad Delco downgraded Marten Transport to Equal Weight from Overweight, citing valuation and its lack of a discount relative to peers following the stock's recent performance. He keeps a $25 price target on Marten Transport shares.
UAL United Continental
$72.66

0.38 (0.53%)

07/12/18
BUCK
07/12/18
NO CHANGE
Target $63
BUCK
Buy
American Airlines selloff overdone, says Buckingham
Buckingham analyst Daniel McKenzie believes American Airlines (AAL) selloff is overdone and reiterates a Buy rating and a $63 price target on the stock. The analyst is attributing slight yield weakness in Q2 to United Continental (UAL) growth across American Airlines markets which decelerates sequentially into Q3, and also, LATAM demand trends that are beginning to pause. Nonetheless, McKenzie believes LATAM does not derail the overall revenue narrative which is poised to improve for the remainder of the year, aided by commercial initiatives, solid domestic demand, and a supply backdrop that improves in key markets.
07/03/18
DBAB
07/03/18
NO CHANGE
DBAB
Deutsche downgrades three airlines on 'headline risk' from trade dispute
Deutsche Bank analyst Michael Linenberg downgraded his ratings on American Airlines Group (AAL), Delta Air Lines (DAL) and United Continental (UAL) to Hold from Buy. The analyst cut his price target for American to $43 from $60, for Delta to $53 from $64 and for United to $74 from $81. In a world of "heightened" macroeconomic and geopolitical risks, economically-sensitive, high beta stocks such as airlines typically underperform the broader market, Linenberg tells investors in a research note. The possibility that the current trade dispute between the U.S. and its global partners could become something bigger is problematic for the airline industry's sales growth, the analyst adds. Further, Linenberg argues, the growing trade dispute may cause U.S. companies to reconsider their spending and employment plans, which would adversely impact corporate travel. As a result, the analyst sees "headline risk" and a lack of near-term catalysts for the airline stocks. He keeps Buy ratings on Alaska Air (ALK), Allegiant Travel (ALGT), JetBlue Airways (JBLU), Southwest Airlines (LUV), Spirit Airlines (SAVE) and SkyWest (SKYW).
07/03/18
07/03/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. United Continental (UAL), American Airlines (AAL), and Delta Airlines (DAL) downgraded to Hold from Buy at Deutsche Bank with analyst Michael Linenberg saying in a world of "heightened" macroeconomic and geopolitical risks, economically-sensitive, high beta stocks such as airlines typically underperform the broader market. 2. Belmond (BEL) downgraded to Underweight from Overweight at Barclays with analyst Felicia Hendrix citing an analysis of the company's progress on its growth targets announced back in June 2016. 3. PSEG (PEG) downgraded to Hold from Buy at Deutsche Bank with analyst Jonathan Arnold saying The Federal Energy Regulatory Commission order raised new questions over New Jersey zero-emission credits. 4. PepsiCo (PEP) downgraded to Hold from Buy at Deutsche Bank with analyst Stephen Powers viewing the current valuation as a "bit bubbly." 5. Watsco (WSO), Fastenal (FAST), and Grainger (GWW) downgraded to Neutral from Outperform at Baird with analyst David Manthey saying he thinks the cycle and individual company results could remain solid for quarters or years to come, but he believes the cycle is in its later stages, thereby elevating risks to gross margins, rising labor costs, and earnings deceleration in 2019. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/16/18
LEHM
07/16/18
NO CHANGE
Target $68
LEHM
Equal Weight
Barclays lowers Airlines targets to reflect 'more realistic' valuations
Barclays analyst Brandon Oglenski reduced his price targets across the North America Airlines group to reflect near-term earnings headwinds from higher fuel prices as well as a "more realistic valuation outlook." Nonetheless, domestic U.S. demand "appears quite strong," with 2018 industry revenue expected to expand high single digits, Oglenski tells investors in a research note. He believes discussion of incremental capacity reductions through earrings season could help put a floor in stock prices. The analyst lowered his price target for Underweight-rated Allegiant Travel Company (ALGT) to $117 from $135, for Equal Weight-rated Alaska Air Group (ALK) to $68 from $80, for Overweight-rated American Airlines Group (AAL) to $60 from $68, for Overweight-rated Delta Air Lines (DAL) to $62 from $73, for Overweight-rated JetBlue Airways (JBLU) to $27 from $29, for Equal Weight-rated Southwest Airlines (LUV) to $65 from $74, for Equal Weight-rated Spirit Airlines (SAVE) to $42 from $49 and for Overweight-rated United Continental Holdings (UAL) to $78 from $80.
CSX CSX
$64.42

0.46 (0.72%)

06/08/18
DBAB
06/08/18
NO CHANGE
Target $79
DBAB
Buy
CSX price target raised to $79 from $70 at Deutsche Bank
Deutsche Bank analyst Amit Mehrotra raised his price target for CSX to $79 after spending time with management. The analyst says that while he's been positive on the shares, he came away "much more positive" on prospective opportunities for cost take-out both with respect to management's focus on cost reduction across the enterprise as well as magnitude of opportunities. The analyst keeps a Buy rating on CSX shares.
05/24/18
STFL
05/24/18
INITIATION
Target $73
STFL
Buy
CSX resumed with a Buy at Stifel
Stifel analyst Michael Baudendistel resumed coverage of CSX with a Buy rating and $73 price target, citing his belief that CSX has the most margin improvement potential of the Class I rails given the initiatives launched by Hunter Harrison and being continued under Jim Foote.
05/14/18
05/14/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. UPS (UPS) upgraded to Buy from Neutral at BofA/Merrill with analyst Ken Hoexter saying he thinks UPS's Network Transformation plan that will be launched in a couple months will improve its cost structure and margins, and could prove to be the turning point for the company and drive the multiple back toward historical levels. 2. FMC Corporation (FMC) upgraded to Buy from Neutral at Goldman Sachs with analyst Robert Koort saying the solid first quarter report convinced him to change his rating as pro forma orgnaic growth rates were very strong, and earnings contribution from the DowDuPont (DWDP) acquisition far exceeded his expectations. 3. L Brands (LB) upgraded to Buy from Neutral at Citi with analyst Paul Lejuez saying he acknowledges this is "not an 'all's clear' type of call," and that things may get worse before they get better, however, he feels consensus sentiment has become so bearish and the stock's valuation is "just too cheap to ignore." 4. Lear (LEA) upgraded to Outperform from In Line at Evercore ISI with analyst Chris McNally saying he sees double digit earnings growth through 2020 with earnings growth set to accelerate in 2019 on the back of the GM truck launch and acceleration of E-Systems given megatrends in Electrification & Connectivity. 5. CSX (CSX) upgraded to Neutral from Sell at Goldman Sachs with analyst Matt Reustle citing better risk/reward following successful execution of Q1 network initiatives. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/14/18
GSCO
05/14/18
UPGRADE
Target $60
GSCO
Neutral
CSX upgraded to Neutral from Sell at Goldman Sachs
Goldman Sachs analyst Matt Reustle upgraded CSX to Neutral and raised its price target to $60 from $52 citing better risk/reward following successful execution of Q1 network initiatives.
MLNX Mellanox
$84.85

0.9 (1.07%)

05/18/18
PIPR
05/18/18
UPGRADE
Target $100
PIPR
Overweight
Mellanox upgraded to Overweight from Neutral at Piper Jaffray
Piper Jaffray analyst James Fish upgraded Mellanox Technologies to Overweight and raised his price target for the shares to $100 from $84. Demand remains strong across servers, storage, and switching as customers refresh and optimize their networking infrastructure, Fish tells investors in a research note. With "renewed focus and execution in the face of activism," the analyst believes Mellanox "can capture on the cycles" in 2018. Further, he thinks the stock still reflects a reasonable valuation despite the recent rally.
06/28/18
LOOP
06/28/18
NO CHANGE
Target $125
LOOP
Buy
Mellanox price target raised to $125 from $100 at Loop Capital
Loop Capital analyst James Kisner raised his price target on Mellanox to $125 and kept his Buy rating after the company's Q2 pre-announcement last month along with its recent agreement with shareholder Starboard Value to set operating margin expansion target. The analyst notes that if Mellanox fails to meet its objective, it would boost the probability of the sale of the company or lead to further operational improvements.
06/20/18
STFL
06/20/18
NO CHANGE
Target $111
STFL
Buy
Mellanox pact with Starboard a win for investors, says Stifel
Stifel analyst Kevin Cassidy said he views Mellanox's director agreement with Starboard as a "significant win" for investors, stating that the addition of successful leaders in the semiconductor industry to the board is important for sustained growth. Mellanox management agreeing to higher operating margin expansion targets is "testimony to management's confidence in new product traction," added the analyst, who keeps a Buy rating and $111 price target on the stock.
06/20/18
PIPR
06/20/18
NO CHANGE
Target $100
PIPR
Overweight
Mellanox agreement with Starboard a 'win-win,' says Piper Jaffray
Piper Jaffray analyst James Fish views the mutual agreement announced by Mellanox Technologies and Starboard as a "win-win" for shareholders. If Mellanox does not execute on its operational plan, which is above expectations, Starboard will likely become directly involved and potentially install someone to execute on the plan, Fish tells investors in a research note. The analyst continues to recommend Mellanox shares with an Overweight rating and $100 price target.
IBKR Interactive Brokers
$64.65

1.93 (3.08%)

04/18/18
RHCO
04/18/18
NO CHANGE
Target $75
RHCO
Hold
Interactive Brokers price target raised to $75 from $62 at SunTrust
SunTrust analyst Douglas Mewhirter raised his price target on Interactive Brokers to $75, saying the underlying metrics of the company's Q1 earnings report reflected "continued strength in account growth, improved net interest income, and greater DARTs per account". The analyst keeps his Hold rating but raises his FY18 EPS target to $2.23 from $2.05, adding that the stock justifies above-peer multiple as it continues to post the highest account and asset growth in the industry.
04/06/18
RSBL
04/06/18
NO CHANGE
Target $65
RSBL
Buy
Interactive Brokers estimates raised on better trading activity at Rosenblatt
Rosenblatt analyst Chris Allen raised Interactive Brokers Q1 earnings estimate to 57c from 48c, FY18 to $2.17 from $2.01, and FY19 to $2.38 from $2.18 to reflect higher DART forecasts from an improved trading backdrop and "exceptional account" growth. Allen raised his price target on Interactive Brokers to $65 and reiterates a Buy rating on shares.
01/17/18
RHCO
01/17/18
NO CHANGE
Target $60
RHCO
Hold
Interactive Brokers price target raised to $60 from $48 at SunTrust
SunTrust analyst Douglas Mewhirter raised his price target on Interactive Brokers to $60 and also raised FY18 EPS estimate to $2.00 from $1.75 following Q4 earnings results. The analyst says the underlying metrics saw continued strength in account growth and improved net interest which were offset by slight weakness in DARTS per account. Mewhirter keeps his Hold rating on Interactive Brokers, adding that the company deserves a premium valuation relative to the industry based on its highest account and asset growth in the online broker space.
04/18/18
WELS
04/18/18
NO CHANGE
Target $60
WELS
Underperform
Interactive Brokers price target raised to $60 from $52 at Wells Fargo
Wells Fargo analyst Christopher Harris raised his price target for Interactive Brokers to $60 from $52 following quarterly results. The analyst reiterates an Underperform rating on the shares.
HCSG Healthcare Services
$42.38

-0.3297 (-0.77%)

06/27/18
JEFF
06/27/18
UPGRADE
Target $53
JEFF
Buy
Healthcare Services upgraded to Buy from Hold at Jefferies
Jefferies analyst Sean Dodge upgraded Healthcare Services to Buy from Hold and raised his price target to $53 from $40, telling investors in a research note that the stock's 26% pullback due to concerns around margins and the health of its end-market presents a rare buying opportunity. These fears are overblown, Dodge contends, as the margin pressure is temporary and not structural and while skilled nursing faces headwinds, the outlook is improving.
06/06/18
WBLR
06/06/18
UPGRADE
WBLR
Outperform
Healthcare Services upgraded to Outperform from Market Perform at William Blair
William Blair analyst Ryan Daniels upgraded Healthcare Services Group to Outperform. The analyst sees an attractive long-term investment opportunity at current share levels.
06/12/18
BNCH
06/12/18
INITIATION
Target $50
BNCH
Buy
Healthcare Services initiated with a Buy at Benchmark
Benchmark started Healthcare Services Group with a Buy rating and $50 price target.
06/27/18
JEFF
06/27/18
UPGRADE
JEFF
Buy
Healthcare Services upgraded to Buy from Hold at Jefferies
TXN Texas Instruments
$115.80

1.21 (1.06%)

07/10/18
ATLE
07/10/18
INITIATION
Target $130
ATLE
Overweight
Texas Instruments initiated with an Overweight at Atlantic Equities
Atlantic Equities analyst Richard Radbourne initiated Texas Instruments with an Overweight and $130 price target.
07/11/18
LBOW
07/11/18
UPGRADE
LBOW
Buy
Texas Instruments upgraded to Buy from Neutral at Longbow
07/17/18
SUSQ
07/17/18
NO CHANGE
SUSQ
Semi lead-times signal strong demand backdrop, says Susquehanna
Susquehanna analyst Christopher Rolland said his primary research reveals modestly expanding lead times for semis during Q2, suggesting a strong demand backdrop. He also suggested it could be due to some over-ordering and noted they are just below the 2011 peak. The analyst believes Q2 is likely to be solid for the group, but adds that over-ordering risks are growing.
07/11/18
07/11/18
UPGRADE
Target $134

Buy
Texas Instruments upgraded to Buy on bullish checks at Longbow
As previously reported, Longbow upgraded Texas Instruments to Buy from Neutral with a $134 price target. Analyst Shawn Harrison said CY2Q semi sales grew +4.5% versus seasonality of +3.9%-4%, connector sales grew +5% sequentially versus seasonality of +3.3%-3.4%, and contacts see CY3 global semi and connector sales 50-60bp better than seasonality. The analyst expects CY2 industry organic sales and CY3 guidance to come in ahead of consensus and views Texas Instruments as a "semi safe haven" during market uncertainty due to free cash flow generation, an under-leveraged balance sheet, aggressive buybacks.
SAH Sonic Automotive
$20.45

0.3 (1.49%)

07/10/18
MSCO
07/10/18
DOWNGRADE
MSCO
Underweight
AutoNation, Sonic Automotive double downgraded to Underweight at Morgan Stanley
Morgan Stanley analyst Armintas Sinkevicius double downgraded AutoNation (AN) and Sonic Automotive (SAH), each to Underweight from Overweight, as he took over coverage of the auto dealer stocks at the firm. Longer term, he is constructive on dealers, citing a belief that tech disruption could accelerate consolidation and set up a transition toward "megafleet managers." However, given that the market is over 9 years into the auto cycle, he sees limited potential for a re-rating of the multiples of auto dealer's stocks, Sinkevicius tells investors. In supporting his view, he notes that both stocks trade at a premium to the rest of the group. Sinkevicius also retains an Underweight rating on Group 1 Automotive (GPI) given its premium valuation.
03/14/18
MSCO
03/14/18
NO CHANGE
MSCO
Morgan Stanley raises U.S. auto sales forecasts through 2021
Morgan Stanley analyst Adam Jonas raised his U.S. seasonally adjusted annual rate, or SAAR, forecast for automakers by an average of 850,000 units from 2018 through 2021, which represents slightly more than a 5% increase from his prior forecast. However, his average U.S. SAAR forecast is still well below last year's 17.3M units and 8% under the cyclical high of 17.6M units in 2016. Jonas points to U.S. tax reform and "relatively stable" recent trends in auto sales and credit as reasons for the hike, noting that while infrastructure action from the federal government could be a material positive, it is not explicitly in his new forecast. Adding that the higher view has a net positive impact on estimates and price targets for exposed auto Original Equipment Manufacturers, or OEMs, and suppliers, Jonas raised his price targets on General Motors (GM), Asbury Automotive (ABG), AutoNation (AN), Group 1 Automotive (GPI), Lithia Motors (LAD), Penske Automotive (PAH), Sonic Automotive (SAH) and Ford (F). He also double upgraded Ford, to Overweight from Underweight, this morning.
01/08/18
BOFA
01/08/18
UPGRADE
Target $23
BOFA
Neutral
Sonic Automotive upgraded to Neutral from Underperform at BofA/Merrill
BofA/Merrill analyst John Murphy upgraded Sonic Automotive to Neutral and raised its price target to $23 from $19 to reflect higher earnings due to tax reform.
10/19/17
10/19/17
DOWNGRADE
Target $19

Sonic Automotive downgraded to Underperform at BofA/Merrill
As previously reported, BofA/Merrill downgraded Sonic Automotive to Underperform from Neutral and cut its price target to $19 from $21. Analyst John Murphy said the US North American automotive cycle is entering a downturn which will pressure profits across the value chain and Sonic's SG&A leverage remains elevated due to new business initiatives which will continue to weigh on earnings.
CARA Cara Therapeutics
$21.60

0.435 (2.06%)

06/27/18
NEED
06/27/18
NO CHANGE
NEED
Cara Therapeutics price target raised to $28 from $23 at Needham
Needham analyst Alan Carr maintained a Buy rating on Cara Therapeutics and raised his price target on shares to $28 from $23, following positive results from Cara's Phase 3 trial of IV CR845 in Post-Surgical Pain, which met its primary endpoint and showed statistically significant impact on Post-Operative Nausea and Vomiting.
06/28/18
HCWC
06/28/18
NO CHANGE
Target $26
HCWC
Cara Therapeutics price target raised to $26 from $24 at H.C. Wainwright
H.C. Wainwright analyst Oren Livnat raised his price target for Cara Therapeutics to $26 saying the company yesterday surprised the Street with a positive IV CR845 Phase 2/3 postoperative pain study. The positive pain trial "certainly adds upside optionality to the story," Livnat tells investors in a research note. He notes, however, that there remains several open questions about the product profile regarding efficacy and potential indication to pursue. Livnat keeps a Buy rating on Cara.
06/28/18
NEED
06/28/18
NO CHANGE
Target $28
NEED
Buy
Cara Therapeutics price target raised to $28 from $23 at Needham
Needham analyst Alan Carr raised his price target on Cara Therapeutics to $28 and kept his Buy rating, citing the company's update on Phase 3 trial of IV CR845 in post-surgical pain. Carr notes that while the low dose missed statistical significance, it trended favorably relative to placebo, and the high dose met the primary endpoint of pain relief. The analyst sees the profile of CR845 as attractive with effective pain relief, low addiction, and low nausea side effects.
05/23/18
HCWC
05/23/18
NO CHANGE
Target $24
HCWC
Buy
H.C. Wainwright says Cara found 'best possible' partner, ups target to $24
H.C. Wainwright analyst Oren Livnat said Cara Therapeutics selected the "best possible partner to maximize IV Korsuva" in signing an agreement with the Vifor/Fresenius joint venture. He views the deal as a "clear positive," stating that it brings in minimally dilutive financing, validates Korsuva, and de-risks the U.S. commercial launch. Livnat increased his price target on Cara shares to $24 from $22 and keeps a Buy rating on the stock.
CASI Casi Pharmaceuticals
$7.26

-0.215 (-2.88%)

01/16/18
HCWC
01/16/18
NO CHANGE
Target $4.5
HCWC
Buy
Casi Pharmaceuticals price target raised to $4.50 from $2 at H.C. Wainwright
H.C. Wainwright analyst Swayampakula Ramakanth raised his price target for Casi Pharmaceuticals to $4.50 saying changes to Chinese regulations could lead to approvals in 2018. Under China's new regulations, if a drug is already marketed overseas, it could directly apply for conditional approval without the need for a clinical study, Ramakanth tells investors in a research note. He notes that management confirmed to him that all three of the company's licensed oncology products, Evomela, Marqibo, and Zevalin, fall under this category. The analyst keeps a Buy rating on Casi.
TLYS Tilly's
$15.35

0.21 (1.39%)

CLX Clorox
$135.00

0.71 (0.53%)

04/20/18
DBAB
04/20/18
NO CHANGE
Target $80
DBAB
Hold
Deutsche Bank downgrades Procter & Gamble, Church & Dwight to Hold
Deutsche Bank analyst Steve Powers downgraded both Procter & Gamble (PG) and Church & Dwight (CHD) to Hold from Buy saying Household & Personal Care is "in a tough spot." The analyst expects incremental pricing pressure to build over the course of 2018 in many categories. Perhaps as a result of tax reform, combined with pre-existing competition, retailers and manufacturers seem willing to reinvest aggressively in order to preserve share, Powers tells investors in a research note. He views this as a "troublesome set-up" for Household & Personal Care names. Along with the two downgrades, the analyst lowered his price targets for Kimberly-Clark (KMB), Edgewell Personal (EPC), Colgate-Palmolive (CL) and Clorox (CLX).
05/03/18
BMOC
05/03/18
NO CHANGE
Target $131
BMOC
Outperform
Clorox price target lowered to $131 from $147 at BMO Capital
BMO Capital analyst Shannon Coyne lowered her price target on Clorox to $131, saying that while Q3 earnings were better than expected, investors have taken down the group multiples on multiple contraction. Coyne also notes the slowdown in Lifestyle and Household segment growth, impacted in part by reduced cold weather demand. The analyst keeps his Outperform rating on Clorox, stating that it should outperform the rest of the group on "stronger pricing power" and digital competency.
07/17/18
GSCO
07/17/18
DOWNGRADE
GSCO
Sell
Clorox downgraded to Sell from Neutral at Goldman Sachs
04/19/18
04/19/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Clorox (CLX) downgraded to Underweight from Equal Weight at Morgan Stanley with analyst Dara Mohsenian saying valuation looks "stretched" on muted earnings growth and lowered his fiscal 2019 earnings estimate by 2% to reflect deterioration in U.S. Household Products sector. 2. Adtran (ADTN) downgraded to Hold from Buy at Argus with analyst Jim Kelleher saying the company has pushed out its expectations for a key client conducting a strategic review of spending, leading to revenue decline for its North America segment to an all-time low. 3. Align Technology (ALGN) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Steve Beuchaw saying his web trends tracking implies growth in the next 1-2 quarters slows to 25% from 35%. 4. ConocoPhillips (COP) downgraded to Hold from Buy at Edward Jones with analyst Jason Gammel citing valuation following the recent rally in the shares. 5. Valvoline (VVV) downgraded to Neutral from Buy at Longbow with analyst Dmitry Silversteyn saying he sees a slower pace of price realization in Quick Lubes combined with a higher cost outlook, limiting earnings upside. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

CSFL

CenterState Banks

$30.36

0.07 (0.23%)

, CHFN

Charter Financial

$24.50

0.07 (0.29%)

09:25
08/21/18
08/21
09:25
08/21/18
09:25
Conference/Events
Charter Financial to host special shareholder meeting »

Special Shareholder…

CSFL

CenterState Banks

$30.36

0.07 (0.23%)

CHFN

Charter Financial

$24.50

0.07 (0.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 24

    Sep

TSLA

Tesla

$308.50

3.17 (1.04%)

, FB

Facebook

$172.50

-1.28 (-0.74%)

09:24
08/21/18
08/21
09:24
08/21/18
09:24
Periodicals
Tesla CEO Musk's Instagram account disappears, Business Insider reports »

Tesla CEO Elon…

TSLA

Tesla

$308.50

3.17 (1.04%)

FB

Facebook

$172.50

-1.28 (-0.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 22

    Aug

  • 06

    Sep

  • 18

    Sep

  • 29

    Oct

KSS

Kohl's

$78.86

2.43 (3.18%)

, NKE

Nike

$82.16

2.43 (3.05%)

09:22
08/21/18
08/21
09:22
08/21/18
09:22
Hot Stocks
Kohl's continues to expect CapEx of approx. $700M for FY18 »

CEO Michelle Gass says…

KSS

Kohl's

$78.86

2.43 (3.18%)

NKE

Nike

$82.16

2.43 (3.05%)

UA

Under Armour

$19.45

0.53 (2.80%)

UAA

Under Armour

$21.23

0.735 (3.59%)

ADDYY

Adidas

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 12

    Sep

WLTW

Willis Towers Watson

$148.02

-0.85 (-0.57%)

09:22
08/21/18
08/21
09:22
08/21/18
09:22
Conference/Events
Willis Towers Watson management to meet with SunTrust »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 22

    Aug

  • 05

    Sep

KEYW

KEYW

$7.74

0.02 (0.26%)

09:19
08/21/18
08/21
09:19
08/21/18
09:19
Hot Stocks
KEYW receives contract award worth over $100M »

KEYW announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

NOV

National Oilwell

$44.16

0.33 (0.75%)

09:18
08/21/18
08/21
09:18
08/21/18
09:18
Upgrade
National Oilwell rating change  »

National Oilwell upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 26

    Oct

SPX

S&P 500

$0.00

(0.00%)

, VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

09:18
08/21/18
08/21
09:18
08/21/18
09:18
Options
Overnight activity included 126 trades in SPX and 10 trades in VIX »

126 trades were executed…

SPX

S&P 500

$0.00

(0.00%)

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Walmart

$95.99

-1.9 (-1.94%)

09:17
08/21/18
08/21
09:17
08/21/18
09:17
Recommendations
Walmart analyst commentary  »

MKM Partners lowers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGS

PlayAGS

$30.84

-0.01 (-0.03%)

09:17
08/21/18
08/21
09:17
08/21/18
09:17
Hot Stocks
PlayAGS to provide its Social White-Label Casino to PokerStars Play »

PlayAGS announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

09:16
08/21/18
08/21
09:16
08/21/18
09:16
Conference/Events
Stephens healthcare analysts to hold an analyst/industry conference call »

Medical Devices Analyst…

BAH

Booz Allen

$49.85

0.11 (0.22%)

09:14
08/21/18
08/21
09:14
08/21/18
09:14
Hot Stocks
Booz Allen awarded $1.03B task order as prime contractor by DHS »

The Department of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXS

Axis Capital

$56.56

0.4 (0.71%)

09:13
08/21/18
08/21
09:13
08/21/18
09:13
Hot Stocks
AXIS names Linda Ventresca chief strategy officer »

AXIS Capital Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

DAVA

Endava

$27.52

-0.63 (-2.24%)

09:13
08/21/18
08/21
09:13
08/21/18
09:13
Initiation
Endava initiated  »

Endava initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADUS

Addus HomeCare

$59.90

0.05 (0.08%)

09:12
08/21/18
08/21
09:12
08/21/18
09:12
Initiation
Addus HomeCare initiated  »

Addus HomeCare initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMT

Lockheed Martin

$324.14

-0.98 (-0.30%)

09:12
08/21/18
08/21
09:12
08/21/18
09:12
Hot Stocks
Lockheed Martin announces GPS III SV02 is available for launch »

As the first Lockheed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ITB

iShares U.S. Home Construction ETF

$37.48

0.13 (0.35%)

09:12
08/21/18
08/21
09:12
08/21/18
09:12
Technical Analysis
Technical Take: iShares U.S. Home Construction ETF may break out »

The iShares U.S. Home…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MARA

Marathon Patent Group

$0.87

-0.0231 (-2.58%)

09:11
08/21/18
08/21
09:11
08/21/18
09:11
Hot Stocks
Marathon Patent Group regains NASDAQ compliance »

Marathon Patent Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$327.75

10.97 (3.46%)

09:10
08/21/18
08/21
09:10
08/21/18
09:10
Recommendations
Netflix analyst commentary  »

Netflix setup for 2H18…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

CTSO

CytoSorbents

$11.83

0.225 (1.94%)

09:10
08/21/18
08/21
09:10
08/21/18
09:10
Hot Stocks
CytoSorbents awarded $3M funding by NHLBI »

CytoSorbents announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

09:10
08/21/18
08/21
09:10
08/21/18
09:10
General news
U.S. equities resumed their firmer path »

U.S. equities resumed…

09:10
08/21/18
08/21
09:10
08/21/18
09:10
General news
FX Action: USD-CAD »

FX Action: USD-CAD traded…

SSNLF

Samsung

$0.00

(0.00%)

, GOOG

Alphabet

$1,207.54

7.75 (0.65%)

09:09
08/21/18
08/21
09:09
08/21/18
09:09
Conference/Events
FedScoop to hold a forum »

8th Annual FedTalks Forum…

SSNLF

Samsung

$0.00

(0.00%)

GOOG

Alphabet

$1,207.54

7.75 (0.65%)

CRM

Salesforce

$145.68

0.67 (0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 21

    Aug

  • 21

    Aug

  • 22

    Aug

  • 29

    Aug

  • 06

    Sep

  • 07

    Sep

  • 10

    Sep

  • 18

    Sep

  • 20

    Sep

  • 24

    Sep

  • 25

    Sep

  • 28

    Oct

ASUR

Asure Software

$13.26

-0.01 (-0.08%)

09:08
08/21/18
08/21
09:08
08/21/18
09:08
Hot Stocks
Asure Software achieves "In Process" status with FedRAMP »

Asure Software announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 06

    Sep

  • 06

    Sep

  • 07

    Sep

  • 13

    Sep

  • 27

    Sep

KSS

Kohl's

$78.86

2.43 (3.18%)

, TJX

TJX

$101.68

1.33 (1.33%)

09:08
08/21/18
08/21
09:08
08/21/18
09:08
Hot Stocks
Fly Intel: Pre-market Movers »

UP AFTER EARNINGS:…

KSS

Kohl's

$78.86

2.43 (3.18%)

TJX

TJX

$101.68

1.33 (1.33%)

AMTD

TD Ameritrade

$60.16

0.76 (1.28%)

SCHW

Charles Schwab

$51.43

0.52 (1.02%)

ETFC

E-Trade

$61.24

0.09 (0.15%)

JPM

JPMorgan

$114.62

-0.13 (-0.11%)

HPE

HP Enterprise

$16.71

0.05 (0.30%)

TLRY

Tilray

$35.91

5.2 (16.93%)

VTL

Vital Therapies

$9.00

(0.00%)

LEN

Lennar

$51.11

0.55 (1.09%)

DHI

D.R. Horton

$44.80

0.42 (0.95%)

TOL

Toll Brothers

$34.72

0.33 (0.96%)

MDT

Medtronic

$90.06

-0.54 (-0.60%)

FN

Fabrinet

$44.00

0.365 (0.84%)

COTY

Coty

$12.41

0.19 (1.55%)

JILL

J.Jill

$7.62

-0.67 (-8.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 21

    Aug

  • 21

    Aug

  • 21

    Aug

  • 21

    Aug

  • 21

    Aug

  • 23

    Aug

  • 28

    Aug

  • 28

    Aug

  • 04

    Sep

  • 05

    Sep

  • 12

    Sep

  • 12

    Sep

  • 12

    Oct

  • 26

    Feb

AMDA

Amedica

$0.36

0.0041 (1.15%)

09:06
08/21/18
08/21
09:06
08/21/18
09:06
Hot Stocks
Amedica announces successful completion of first spine fusion surgery with Valeo »

Amedica announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.